EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




Each of the undersigned hereby certifies, in his capacity as an officer of
Peregrine Pharmaceuticals, Inc. (the "Company"), for purposes of 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to his knowledge:


         (1) the Quarterly Report of the Company on Form 10-Q for the period
ended July 31, 2003 fully complies with the requirements of Section 13(a) or
Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
amended; and

         (2) the information contained in the Quarterly Report fairly presents,
in all material respects, the financial condition and results of operations of
the Company.


Date:    September 12, 2003
         ------------------

/s/ Steven W. King
- ----------------------------
Steven W. King
PRESIDENT AND CHIEF EXECUTIVE OFFICER


/s/ Paul J. Lytle
- ----------------------------
Paul J. Lytle
CHIEF FINANCIAL OFFICER



A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN
PROVIDED TO PEREGRINE PHARMACEUTICALS, INC. AND WILL BE RETAINED BY PEREGRINE
PHARMACEUTICALS, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR
ITS STAFF UPON REQUEST.